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Abstract
Background: Individual and sociocultural factors may pose significant barriers for drug abusers
seeking treatment, particularly for African-American crack cocaine abusers. However, there is
evidence that pretreatment interventions may reduce treatment initiation barriers. This study
examined the effects of a pretreatment intervention designed to enhance treatment motivation,
decrease crack use, and prepare crack abusers for treatment entry.
Methods: Using street outreach, 443 African-American crack users were recruited in North
Carolina and randomly assigned to either the pretreatment intervention or control group.
Results:  At 3-month follow-up, both groups significantly reduced their crack use but the
intervention group participants were more likely to have initiated treatment.
Conclusion:  The intervention helped motivate change but structural barriers to treatment
remained keeping actual admissions low. Policy makers may be interested in these pretreatment
sites as an alternative to treatment for short term outcomes.
Background
Sociocultural factors may pose significant barriers for drug
abusers seeking health care or substance abuse treatment.
These barriers may be particularly problematic for some
African-Americans and other disadvantaged populations.
To help reduce the negative behaviors and outcomes asso-
ciated with substance abuse and dependence, new inter-
vention models need to be developed that specifically
address the sociocultural environment of ethnic minori-
ties [1]. Moreover, recent research has recognized the need
to enhance understanding of crack cocaine dependence
and how crack abusers interact with the substance abuse
treatment system [2].
Crack is a cheaper and smokable form of cocaine that
became widely available in the mid-1980s, and it contin-
ues to be a public health problem in the United States.
Crack use is present among all ethnic groups [3], but it is
most common among African-Americans residing in low-
income inner-city neighborhoods [4-7]. Findings from
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the 2001 National Household Survey on Drug Abuse
(NHSDA) indicated that African-Americans made up 12%
of the U.S. population, but they represented 19% of indi-
viduals who had used crack in the past year [8]. In addi-
tion, crack dependence rates are reported to be higher
among African-Americans than among Hispanics or
Whites [4]. Furthermore, cocaine-related emergency room
episodes and overdose deaths were more common among
African-Americans than any other racial/ethnic group
[4,9].
The prevalence of crack use among African-Americans
only partially explains differential drug use across racial/
ethnic groups. Many frequent crack abusers are older,
unemployed, without health insurance, susceptible to
health risks from their use of cocaine, and more likely to
be living in social environments where there is increased
risk for crack use [10,11]. Moreover, barriers to treatment
among African-Americans who abuse crack have not been
well researched, although some findings indicate that
African-Americans do not have the resources to enter
treatment [12].
Harm-reduction outreach efforts specifically targeting
hard-to-reach drug users have been successful in reaching
out-of-treatment substance abusers [13]. However, many
crack abusers are not accessing drug treatment from spe-
cialty programs, such as inpatient or outpatient drug reha-
bilitation facilities or mental health centers, even when
offered free coupons for treatment [14]. Instead, they pre-
fer to seek help from health and social service programs,
such as emergency room services or self-help groups [15].
The findings from an earlier North Carolina study target-
ing out-of-treatment African-American injecting drug
users (IDUs) and crack abusers for HIV risk reduction sug-
gest that although IDUs can access methadone treatment,
crack abusers have more difficulty accessing treatment
services [16].
Individual-level barriers to treatment entry also exist, such
as motivation and treatment readiness. Motivation for
treatment has been conceptualized in a three-stage model
consisting of problem recognition, desire for help, and
readiness for treatment [17]. Research has shown that
problem recognition is a key step in treatment entry
[18,19]. Despite its importance, relatively few studies
have examined motivation among out-of-treatment Afri-
can-American crack abusers and its relationship to treat-
ment initiation. One study examined differences between
African-American crack abusers who reported being ready
for treatment in the next 30 days and those who were not
ready. The findings indicated that treatment readiness was
significantly associated with problem recognition [20].
Thus, self-recognition that drug use is a problem may be a
critical first step in the treatment initiation process.
Even when minority crack abusers want treatment, vari-
ous external barriers may prevent them from gaining
access. The extent of their drug use, economic liabilities,
and the drug-user lifestyle may be determining factors, but
additional structural barriers – such as cost, transporta-
tion, cultural competency, daycare, gender bias – also
keep treatment programs from reaching and retaining
these populations in their programs [13,21].
The demands of drug treatment programs are often based
on models that lack cultural sensitivity to minorities or
women. For example, some people may find aspects of
the initial involvement in these programs – such as self-
disclosure, trust in virtual strangers, being urged to "sur-
render" or admit they are "powerless" – to be alien and
culturally inappropriate. Therefore, if African-Americans
are tentative about seeking treatment, outreach referral
and intake need to be conducted in a culturally congruent
manner [22].
A number of studies support the idea that pretreatment
interventions and strategies may be effective in facilitating
treatment entry and increasing treatment retention for
substance abusers. One survey of studies that have tested
various pretreatment strategies concluded that more
research was needed to evaluate which strategies or com-
binations of strategies are most effective [23].
Previous studies have found that for African-Americans
there is a need for greater cultural congruence and appro-
priate consideration of their readiness for treatment,
including whether or not they have the confidence and
self-efficacy to enter and benefit from substance abuse
treatment. To address the needs of African-American crack
abusers, a culturally congruent Pretreatment Intervention
to enhance treatment motivation and readiness, decrease
crack use, and prepare crack abusers for treatment entry
was developed and tested. This study examines the effec-
tiveness (at 3- and 6-month follow-ups) of the Pretreat-
ment Intervention compared with a delayed treatment
control condition to reduce drug use and encourage treat-
ment initiation and participation.
Methods
Outreach and recruitment
Participants were recruited in Raleigh, North Carolina, by
indigenous community outreach workers who were them-
selves in substance abuse recovery. Individuals were
screened and recruited according to a prespecified sam-
pling plan through standardized street-outreach tech-
niques, peer-advocate chain referral, and self-referral
procedures that have been used in numerous community
studies [14,36]. Outreach workers were trained to
approach and screen individuals in inner-city neighbor-
hood segments to ensure that the sample comprised mul-Substance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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tiple communities and social groups. The total number of
out-of-treatment African-American crack abusers recruited
through these procedures between August 2000 and
August 2002 was 567 individuals. Of these, 443 com-
pleted the two intake interviews and were randomly
assigned to either the intervention or control group.
Eligibility
Individuals who met eligibility criteria during the screen-
ing process on the street were referred to the field site for
final determination of eligibility. Participants who met
the preliminary criteria indicated that they had an interest
in substance abuse treatment and had the intention to
reduce or stop drug use within the next 6 months. Other
eligibility criteria included self-identifying as African-
American, being at least 18 years of age, having no formal
substance abuse treatment within the past 90 days, either
having a positive urine test for a cocaine metabolite or
self-reporting crack use on at least 13 of the past 90 days,
and using crack more frequently than injecting drugs.
Data collection
All study participants who gave informed consent were
assessed by self-report at a two-part intake occurring 2
weeks apart, and at 3- and 6-month follow-ups. Each data
collection session took about 90 minutes to complete and
was conducted using a computer-assisted personal inter-
view (CAPI) protocol. Informed consent and data collec-
tion procedures were approved by RTI International's
Office of Research Protection and Ethics.
The assessment questionnaires consisted of items and
scales drawn from standardized instruments, including
the Global Appraisal of Individual Needs (GAIN) [37]
and the Texas Christian University (TCU) Treatment Moti-
vation Scales [38], as well as items developed specifically
for this study by the research team. The instruments were
pilot tested prior to study implementation.
The domains assessed at intake included the following:
sociodemographic characteristics, basic needs, historical
and current alcohol and other drug use, history of sub-
stance abuse treatment, barriers to treatment, motivation,
readiness, sexual behavior, physical and mental health,
interpersonal violence, criminality, interpersonal rela-
tionships, and social support. Follow-up assessments
focused on changes in the above-mentioned domains.
Participants received $10 compensation at intake 1, $15 at
intake 2, and $25 and $30 for the 3- and 6-month follow-
up interviews, respectively. Drug use was verified by uri-
nalysis (using Roche Diagnostic System's OnSite/On
Trak™) for alcohol, marijuana, opioids, and cocaine
metabolites at intake 1 and at 3- and 6-month follow-ups.
After completing intake 1, participants attended an HIV
pretest counseling session and were offered HIV antibody
testing. HIV posttest counseling was scheduled to coincide
with intake 2 approximately two weeks later.
Intervention
Following the second intake session, participants were
randomly assigned to one of two study conditions: the
Pretreatment Intervention group or a delayed treatment
control group. The Pretreatment Intervention aimed to
provide African-American crack abusers with personalized
feedback about their drug use and associated problems,
information about the treatment process, and skills to
enhance individual responsibility to reduce drug use. The
intervention also provided assistance in developing
appropriate social support systems in an environment in
which they feel safe and accepted.
It is likley that African-American crack abusers would have
a variety of preexisting conditions that could impact their
readiness for treatment and that there would be substan-
tial differences between individuals regarding these condi-
tions. Within this context, the Pretreatment Intervention
emphasizes a supportive environment for African-Ameri-
can participants, education in the process of becoming a
substance abuse treatment patient, and help in under-
standing the concepts of recovery. The intervention para-
digm supports the conceptual framework with a four-
stage approach consisting of (1) the patient's awareness of
a problem, (2) the patient's understanding of how to fix
the problem, (3) an open attitude to change on the part of
the patient, and (4) behavior or action that shows positive
movement [16].
This paradigm forms the basis for translating the concep-
tual framework into a workable protocol to enhance treat-
ment readiness through a variety of well-known
intervention strategies, including motivational interview-
ing [39], role induction [40-42], and social skills building
[43,44]. A combination of intervention strategies is likely
to be more effective than a single strategy [23].
The intervention consisted of one individual session and
two group sessions conducted over a one-month period.
Three African-American individuals (one male and two
females) who were indigenous to the community and in
substance abuse recovery were hired and trained to deliver
the intervention. The sessions were designed to increase
treatment readiness and motivation, to assist in reducing
external barriers to treatment entry, and to increase under-
standing of the patient's role in treatment induction and
the treatment process. The individual session immediately
followed intake 2, and the group sessions were scheduled
to occur within 2 weeks of the prior session.
During the 90-minute individual session, the interven-
tionist used motivational interviewing techniques toSubstance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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review individual problem areas with the participant,
including barriers to treatment that he or she reported
during the data collection interviews. This personalized
assessment of drug use, sexual risk, and treatment history
allowed participants to develop an individualized plan of
action to reduce risk behaviors and enter drug treatment
based on their unique life situation. Personal plans
focused not only on drug treatment and risk behaviors,
but also on life issues such as education, employment,
housing, and parenting.
The one-hour group sessions used a support-based format
to help participants understand how they are affected by
the multiple contextual influences in their lives, and to
teach portable skills to reduce risk and increase problem-
solving skills and awareness of options for treatment
entry. Some of the methods used included group role-
playing and rehearsal of new skills as a means to experi-
ence new social skills and to increase self-efficacy.
Topics discussed during the group sessions included con-
sequences of drug use, warning signs for increased use
(e.g., visiting hangouts), developing healthy lifestyle
behaviors (e.g., sober friends, clean housing, positive sup-
port systems), assertive responses (e.g., learning to
respond to triggers by role-playing and rehearsing asser-
tive and proactive responses to anticipated scenarios),
dealing with the return of obsessive use (relapse) as an
opportunity for learning, and relationship and prevention
enhancements. Participants also received information for
developing support networks and linkages to social serv-
ices. Group sessions also sought to help participants clar-
ify what it means to be in treatment, what treatment can
offer them, and what they must be prepared to do.
The study's main hypothesis postulated that the Pretreat-
ment participants would be more likely to initiate treat-
ment and enter treatment. The control group received no
intervention during the first 6 months of study enroll-
ment. At 6-month follow-up, individuals in the control
group were invited to participate in the Pretreatment
Intervention: 10% of study participants (n = 22) attended
both the individual session and at least one group session.
Study sample
The experimental sample comprises 443 male and female
out-of-treatment crack abusers who completed both Part
1 and Part 2 of the baseline interview, were randomly
assigned to the intervention or control group, and had
complete data for the key variables of interest. Compari-
sons were made on demographics and drug use between
individuals who completed both Part 1 and Part 2 (the
current sample), and the 104 individuals who completed
only Part 1 of the baseline. There were no significant dif-
ferences in gender, age, education, homelessness, daily
crack use, or daily alcohol use. Analyses of the interven-
tion effect included individuals who were randomly
assigned and completed either the 3-month or the 6-
month follow-up. Ninety percent of the sample com-
pleted the 3-month follow-up (n = 400) and 89% com-
pleted the 6-month follow-up (n = 396). Because of the
low attrition rate, baseline statistics are reported for the
entire baseline sample. Table 1 presents the background
characteristics of the sample.
Measures
Outcome measures
Four primary outcomes were examined. Treatment entry
at the 3-month and 6-month follow-up was assessed by
the question, "During the past 90 days, did you enter a
drug treatment program?" This was coded as a dichoto-
mous variable (yes-no). Treatment initiation at the 3-
month follow-up was assessed from three items that asked
respondents if they made an appointment with a drug
treatment program, tried to enter a treatment program, or
entered a treatment program in the past 90 days. A yes
response to any of these items was considered treatment
initiation. This was coded as a dichotomous variable (yes-
no). Treatment initiation at 6 months was measured using
these three items from the 3-month and the 6-month fol-
low-ups. If individuals responded positively to any of
these three items at the 3-month or the 6-month follow-
up, they were coded as yes for the 6-month follow-up.
Crack use at baseline, 3-months, and 6-months was meas-
ured as the number of days crack was used in the past 30
days. Three measures of alcohol use were examined. Alco-
hol frequency was measured as the number of days of
alcohol use in the past 30 days. Alcohol quantity was
measured as the number of days an individual drank five
or more drinks in one day in the past 30 days, and the
number of drinks per day in the past 30 days. Table 2
presents the variable definitions and reliability scores for
the measures.
Covariates
Several demographic measures were included as covari-
ates. Age was entered as a continuous variable; gender was
included as a dichotomous variable, with male coded as 1
and female coded as 0. Treatment readiness was entered as
a categorical variable that was constructed from two other
variables: (1) Do you want to go to treatment? (yes-no);
and (2) How soon do you want to go to treatment?
(within next 30 days, next 1–6 months, not within the
next 6 months).
Analyses
Analyses of changes in crack and alcohol use compared
the within-group differences in the means of the interven-
tion and control group between baseline and 3-month
follow-up, and baseline and 6-month follow-up. Statisti-Substance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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cal significance of changes in crack and alcohol use was
assessed using paired t-tests.
The effect of the intervention assignment on treatment
initiation at 3 and 6 months was estimated and tested
using multiple logistic regression, with age, gender, and
treatment readiness at baseline entered as covariates.
To assess comparability, the intervention and control
groups were compared on baseline demographic variables
and other potentially important variables. There were sev-
eral significant group differences. The intervention group
reported significantly more alcoholic drinks per day in the
previous 30 days compared with the control group, (mean
= 9.3, S.D = 11.1 versus mean = 6.7, S.D = 7.3, p = 0.009;
t = -2.6, df = 439), scored lower on the treatment resist-
ance index (mean = 2.0, S.D. = 1.3 versus. mean = 2.3, S.D.
= 1.5, p = 0.036, t = -0.28, df = 440,), and scored lower on
drug use problem recognition, (mean = 8.4, S.D. = 2.9 ver-
sus mean = 9.0, S.D. = 2.6, p = 0.032, t = -2.1, df = 440).
However, these variables were tested in the multivariate
models and did not account for group differences in out-
comes.
Results
Table 3 presents the baseline, 3-month follow-up, and 6-
month follow-up data for each of the primary study out-
comes.
Crack and alcohol use
Both groups reported very substantial decreases in the
mean number of days of crack use between baseline and
3- and 6-month follow-ups – from about 15 days to about
8 days of use in the previous 30 days. There were no sta-
Table 1: Background Characteristics of Study Sample at Baseline
Characteristic All Participants (N = 443)
Sociodemographic
% Male 73.1
Mean age (S.D.) 39.9 (7.8)
% Married or living with partner 16.3
% High school graduate 50.1
% Employed full time 32.0
% Currently homeless 38.1
% Have any type of health insurance 21.3
% Any type of criminal justice involvement 15.1
Drug Use, Treatment History
Mean number days smoked crack past 30 days (S.D.) 15.3 (10.4)
% Used alcohol daily past 30 days 32.8
Mean number days drank 5+ drinks past 30 days (S.D.) 11.6 (11.5)
% Used crack daily past 30 days 19.4
Mean number years crack use (S.D.) 13.1 (6.8)
% Ever in drug treatment 59.6
Mean number treatment episodes (S.D.) 1.6 (2.5)
Motivation, Readiness to Change
Mean Problem Recognition scale score (S.D.) 8.7 (2.8)
Mean Desire for Help scale score (S.D.) 6.2 (1.3)
Mean Treatment Resistance Index scale score (S.D.) 2.1 (1.4)
% in Preparation Stage of Change – alcohol use 71.6
% in Preparation Stage of Change – crack use 84.2
% in Preparation Stage of Change – treatment entry 64.3
Barriers to Treatment
% Transportation 69.7
% Childcare 8.6
% Scheduling around work, school, or family responsibilities 42.1
% Paying for treatment 75.1
% Religious, ethnic, or cultural issues 10.4
Psychological Symptoms
Mean depression scale score (S.D.) 2.3 (2.0)
Mean anxiety scale score (S.D.) 1.1 (1.2)Substance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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tistically significant differences in frequency of crack use
between the intervention and control group at any point.
Similarly, both groups reported significant decreases in
number of days of alcohol use, number of days drank five
or more drinks, and number of drinks per day. There were
no significant differences between groups on any of these
measures.
Treatment initiation
Very few participants entered a treatment program at
either the 3- or 6-month follow-up (Table 3). Only 7.6%
of the intervention group and 5.5% of the control group
reported entering treatment at the 3-month follow-up.
Similarly low numbers are seen for the 6-month follow-
up. These group differences were not significant at either
time point. However, a significantly greater proportion of
participants from the intervention group (20.2%) com-
pared with the control group (12.5%) engaged in treat-
ment initiation, which included calling a program,
making an appointment, or entering treatment.
Table 4 presents the results from the logistic regression
predicting the odds of treatment initiation at the 3- and 6-
month follow-ups. Controlling for readiness for treat-
ment, homelessness and number of lifetime treatment
episodes, individuals in the intervention group had signif-
icantly higher odds of treatment initiation compared with
the control group at the 3-month follow-up (OR = 1.89,
Wald chi-square = 6.01, df = 1, p = 0.014). In addition,
individuals in higher stages of change, who were home-
less at baseline, and who had experienced more lifetime
treatment episodes had higher odds of initiating treat-
ment at the 3-month follow-up. At the 6-month follow-
up, however, intervention assignment was not signifi-
cantly associated with treatment initiation.
Discussion
The low rates of treatment entry at 3-month follow-up
(7.5% and 5.5% in the intervention and control groups,
respectively) and at 6-month follow-up (10.0% and 8.7%
in the intervention and control groups, respectively) are
disappointing, but they are not surprising. When extrapo-
lated to a one-year period, they are quite similar and pos-
sibly higher than the rates of treatment entry in a
prospective observational study of crack abusers in which
about 13% per year entered treatment [24].
Table 2: Variable Definitions and Reliability Scores
Measure Definition Response Category Chronbach alpha
Treatment Motivation
Problem Recognition Awareness of drug problems as measured by items 
adapted from the Problem Recognition scale of 
the TCU Motivation for Treatment Scales [38]
9 items
Yes = 1, No = 0
0.82
Desire for Help Awareness of intrinsic need for change in drug use 
and interest in getting help is measured by items 
adapted from the Desire for Help scale of the 
TCU Motivation for Treatment Scale [38]
7 items
Yes = 1, No = 0
0.72
Treatment Resistance Perception of difficulties in being in treatment and 
resisting use [37]
4 items
Yes = 1, No = 0
0.47
Lifetime Treatment Episodes Reported number of times been to treatment in 
lifetime
1 item Continuous
Readiness for Treatment Desire to go to drug treatment, and how soon 
individual would want to go
2 items
Precontemplation = Do no want to 
or want to go 6+ months from 
now
Contemplation = Want to go 1–6 
months from now
Preparation = Want to go in next 
30 days
Readiness to Change Alcohol Use Desire to change alcohol use 2 items (same categories as above)
Readiness to Change Crack Use Desire to change crack use 2 items (same categories as above)
Years of Crack Use Number of years since first crack use to baseline 1 item
Continuous
Psychological Functioning
Depressive Symptoms Significant problems with depressive symptoms 
reported in the past 90 days adapted from the 
GAIN Depressive Symptoms Scale [37]
5 items
Yes = 1, No = 0
0.88
Anxiety Significant problems with symptoms of anxiety 
reported in the past 90 days adapted from the 
GAIN Anxiety Symptom Index [37]
3 items
Yes = 1, No = 0
0.77Substance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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Some factors that may help explain the low rates of treat-
ment entry in the present study include (1) 68% of the
sample was unemployed, (2) 79% was uninsured, (3)
75% indicated that they would need help paying for treat-
ment, and (4) 70% reported that they would need help
with transportation. Unfortunately, free or subsidized
treatment was not readily available during the study
period. For most of the period, the primary program to
which participants were referred charged an intake fee of
$75, and the location of the treatment program was
inconvenient for many participants.
Given these circumstances, intervention effects on treat-
ment initiation were examined. Initation was defined as
making an appointment, attempting to enter treatment or
entering treatment. The finding at 3-month follow-up that
participants in the intervention group were significantly
more likely to initiate treatment than participants in the
control group (20% vs. 12%) suggests that the interven-
tion was moderately successful in increasing motivation
for treatment. The relatively large difference between par-
ticipants in the intervention group who initiated treat-
ment (20%) and those who actually entered treatment
(7.5%) suggests a need for structural changes that reduce
treatment program barriers. In particular, changes may be
needed to address barriers related to the financial cost,
which was reported by 75% of participants, transporta-
tion reported by 68%, child care reported by 10%, and
scheduling difficulties by 42%.
This interpretation is consistent with findings from previ-
ous studies that have shown that coupons and other tech-
niques for removing financial barriers to treatment are
effective in increasing treatment entry [13,25-27]. None-
theless, the potential impact of readily available free treat-
ment on treatment entry in the 80% of participants in the
intervention that did not initiate treatment is difficult to
predict. Self-efficacy theory suggests that more people
would attempt to enter treatment if they thought that the
attempt would be successful [28]. However, other factors,
such as possible perceptions regarding the limited effec-
Table 3: Group Means at Baseline, and 3-Month and 6-Month Follow-ups
3-Month Follow-up 6-Month Follow-up
Variable Baseline I (N = 198) C (N = 200) I (N = 196) C (N = 198)
% Entered Treatment Past 90 Daysa
Intervention 7.6 10.0
Control 5.5 8.7
% Made appt./tried/entered Treatmenta
Intervention 20.2* 24.2
Control 12.5 18.3
Mean (S.D.) Mean (S.D.) DF Mean (S.D.) DF
# Days Crack Usea,b
Intervention 15.1 (10.4) 8.5 (9.4)*** 196 6.6 (8.9)*** 193
Control 15.2 (10.5) 8.1 (9.3)*** 199 6.3 (8.5)*** 197
# Days Alcohol Usea,b
Intervention 17.3 (11.9) 12.8 (11.1)*** 196 11.5 (10.6)*** 195
Control 17.2 (11.8) 11.9 (10.7)*** 197 12.0 (10.5)*** 197
# Days Drank 5+ Drinksc,d
Intervention 10.3 (11.5) 6.0 (9.0)*** 197 5.7 (9.1)*** 195
Control 10.1 (11.7) 6.3 (9.5)*** 197 5.9 (8.4)*** 197
# Drinks/Dayc,d
Intervention 9.3 (11.4) 4.6 (7.6)*** 196 5.2 (9.4)*** 194
Control 6.7 (7.4) 4.3 (4.1)*** 196 4.6 (4.8)** 196
*p < .05, **p < .01, ***p < .001
aComparisons are between groups
bP-values are calculated using Pearson chi-square test
cComparisons are from baseline to 3-month follow-up and from baseline to 6-month follow-up
dP-values are calculated using paired t-tests'.
DF = Degrees of freedomSubstance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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tiveness of current treatments for crack abusers, may
reduce the impact of increased access to treatment.
As with many other intervention studies with out-of-treat-
ment drug users, participants in both groups reported sig-
nificant decreases in drug and alcohol use and risk
behaviors between baseline and follow-up interviews, but
differences between groups were not significant [25,29-
31]. Moreover, studies reporting negative findings may
substantially underestimate the number of studies with
negative findings because of publication bias [32-34]. In
the studies by Simpson et al. [30] and Stephens et al. [31],
for example, the specific causal mechanisms effecting
change have proven particularly difficult to disentangle.
The substantial reductions in drug use and HIV risk that
have been reported by participants in these studies,
regardless of intervention condition, raise the possibility
that the choice to participate may represent a decision to
begin changing behavior.
The present study, in which significant, but similar,
decreases in alcohol and other drug use were reported by
participants in the control group and the intervention
group is no exception. Possible explanations for these
findings include the warm atmosphere at the field site,
interactions with recovering staff, and the effects of the
interview itself. In addition, the intervention effects of
interacting with outreach workers outside of the site,
which have been summarized previously, may have had
an important impact on behavior [35]. From anecdotal
data collected at these sites, participants felt that they were
part of the study, and the questions that were asked made
them begin to want to make positive changes. Despite the
fact that data collection and intervention tasks were per-
formed by different staff and interviewers were trained in
techniques for reducing socially desirable responses,
social desirability cannot be totally ruled out.
As with almost all studies of out-of-treatment drug users,
this study suffers from several potential limitations.
Changes in drug use and treatment initiation are based on
self-reports. Although interviews were conducted by inter-
viewers experienced in working with this population and
trained in techniques for minimizing socially desirable
responses, some responses may be inaccurate because of
faulty memory or intentional misreporting. In addition,
although a targeted sampling approach was used to
increase generalizability, it is not possible to determine
the representativeness of the sample; so caution should be
used in generalizing these findings to other groups of
crack abusers. Fifty-six participants reported a history of
injection drug use, but only reported injecting in the past
30 days. Consequently, caution should used in generaliz-
ing these findings to IDUs that use crack. In addition,
although there were over 200 participants in the interven-
tion and control groups, given the small percentage of
participants entering treatment the study may have had
insufficient statistical power to detect small or medium
effect sizes.
Conclusion
The extremely high follow-up rates – about 95% of partic-
ipants in each of the intervention and control groups
completed at least one follow-up and 84% completed
both follow-ups – increase confidence in the finding that
involvement in the study was directly associated with sig-
nificant decreases in crack use. Additionally, qualitative
interviews with a small number of participants (n = 18) as
well as anecdotal reports from field staff strongly suggest
that simply coming to the study's field study office was
important for participants in the control group. Qualita-
tive data also suggest that many participants in the inter-
vention group felt that the intervention was "treatment" –
or at least a satisfactory substitution for it – and that most
participants felt they could not commit to treatment given
the individual and structural treatment barriers they faced.
Nonetheless, both groups reported significant reductions
in crack use. However the goal to access treatment for the
experimental group was mixed. Although there were sig-
nificant findings in initiation, access was still problematic
due to structural barriers from the treatment programs
even for those attempting to enter.
Table 4: Logistic Regression Models for Treatment Initiation at 3-Month and 6-Month Follow-ups
3 Month Follow-up OR 95% CI 6 Month Follow-up OR 95% CI
Group Assignment
Control (ref) 1.00 1.00
Intervention 1.89* (1.04–2.34) 1.48 (0.90–2.42)
Ready to Change – 
Treatment
2.14** (1.06–3.73) 1.66** (1.15–2.39)
Homeless 1.84* (1.04–3.24) 2.04** (1.24–3.33)
Lifetime Treatment 
Episodes
1.16** (1.04–1.31) 1.14* (1.03–1.26)
*p < .05, **p < .01 (p-values are based on the Wald chi-square test with 1 degree of freedom; constant is included in the model)Substance Abuse Treatment, Prevention, and Policy 2007, 2:10 http://www.substanceabusepolicy.com/content/2/1/10
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Because crack abuse continues in many poor communi-
ties, outreach and pretreatment sites may offer policy
makers options for initiating treatment and reducing drug
use. Determining the costs of such a site and identifying
the essential elements of a brief pretreatment interven-
tion, similar to the drop-in centers of years past, may be
an important next step to understanding the feasibility of
this strategy to reduce barriers to treatment. It is unclear
whether site, staff, intervention, or even instrumentation
components have an effect. Positive changes occur, but it
remains difficult to disentangle which components are
the most critical ones.
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